Elena Korneva

Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis

Josef S Smolen, Eugen Feist, Saeed Fatenejad et al. · New England Journal of Medicine · 2022 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study

Evgeniy Nasonov, Saeed Fatenejad, Eugen Feist et al. · Annals of the Rheumatic Diseases · 2021 · 72 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study

Eugen Feist, Saeed Fatenejad, Sergey Grishin et al. · Annals of the Rheumatic Diseases · 2022 · 43 citations · Full text

Medicine, Immunology, Pharmacology +16

Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies

Mark C. Genovese, Patrick Durez, Roy Fleischmann et al. · European Journal of Rheumatology · 2021 · 10 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15